Monopar Therapeutics Inc. · NASDAQ:MNPR
AstraZeneca PLC reported a 7.80% stake in Monopar Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 6, 2026
AstraZeneca PLC reported a 7.80% stake in Monopar Therapeutics Inc., 522,667 shares, as a passive investor on Dec 31, 2025. Filed Feb 6, 2026 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 522,667
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AstraZeneca PLC | 7.80% | 522,667 |
| Alexion Pharmaceuticals, Inc. | 7.80% | 522,667 |